Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jun 10;16(6):e0251736. doi: 10.1371/journal.pone.0251736

COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19

Andrea Siebenhofer 1,2,#, Sebastian Huter 3,#, Alexander Avian 4,*, Karola Mergenthal 2, Dagmar Schaffler-Schaden 3, Ulrike Spary-Kainz 1, Herbert Bachler 5, Maria Flamm 3
Editor: Kamal Gholipour6
PMCID: PMC8191874  PMID: 34111120

Abstract

Background

Coronavirus disease 2019 (COVID-19) represents a significant challenge to health care systems around the world. A well-functioning primary care system is crucial in epidemic situations as it plays an important role in the development of a system-wide response.

Methods

2,187 Austrian and German GPs answered an internet survey on preparedness, testing, staff protection, perception of risk, self-confidence, a decrease in the number of patient contacts, and efforts to control the spread of the virus in the practice during the early phase of the COVID-pandemic (3rd to 30th April).

Results

The completion rate of the questionnaire was high (90.9%). GPs gave low ratings to their preparedness for a pandemic, testing of suspected cases and efforts to protect staff. The provision of information to GPs and the perception of risk were rated as moderate. On the other hand, the participants rated their self-confidence, a decrease in patient contacts and their efforts to control the spread of the disease highly.

Conclusion

Primary care is an important resource for dealing with a pandemic like COVID-19. The workforce is confident and willing to take an active role, but needs to be provided with the appropriate surrounding conditions. This will require that certain conditions are met.

Registration

Trial registration at the German Clinical Trials Register: DRKS00021231.

Introduction

Coronavirus disease 2019 (COVID-19) represents a significant challenge to health care systems around the world. Although implications for the hospital and intensive care sector are generally focused on, a comprehensive approach to managing the COVID-19 pandemic should also involve primary care, as it is usually the point-of-first-contact, regardless of patients`health concerns [1, 2]. In a pandemic, it is therefore particularly important that primary care is in a position to provide the continuous care that is needed, especially when other parts of the system are overwhelmed [3].

Primary care professionals represent the first point of contact in health care systems and are therefore in a vulnerable position. With sometimes insufficient information, they must deal with a dilemma between caring for potentially infectious patients [4], while protecting themselves and those around them from contracting the disease [5, 6]. Previous studies have emphasized the need to include general practitioners in preparedness planning and in supplying them with the personal protective equipment (PPE) they require to quickly adapt to highly dynamic epidemiological developments [7, 8]. While scenarios comparable to the COVID-19 pandemic have been simulated [9], national response plans in many countries still tend to neglect the primary care sector [10]. Furthermore, primary care in Austria and Germany is mostly delivered in small, decentralized units run by self-employed general practitioners (GPs), which may hinder a rapid and coordinated pandemic response [11].

Neither Germany nor Austria have yet exhausted their intensive care capacities and have managed to keep infection numbers under control [12, 13]. Nevertheless, it remains unclear how long the COVID-19 pandemic will last. Primary care will likely have to deal with recurring waves of infections, at least in certain regions, especially since dealing with viral infections is part of the daily business of general practice [14].

The aim of this study is to investigate the role played by GPs in the early phase of the COVID-19 pandemic, the specific challenges faced by them, their concerns and the strategies they have developed to cope with the pandemic. Potential deficiencies as well as regional differences (country-specific, setting, urbanity) are analyzed.

Methods

This manuscript was prepared in accordance with the CHERRIES criteria [15] (Supporting Information A-13). COVI-Prim-Start is part of the international COVI-Prim project [16]. Since this is the first publication to emerge from the project, the methods and design of the study are described in detail in the Supplement.

Questionnaire development

To create a basic pool of items for the COVI-Prim questionnaire, we searched the literature for studies investigating the role of general practice during pandemics. Various topics, which had been partially grouped in topic areas in the literature, were identified. New topic areas were created for topics that did not belong in those found in the literature. Based on the literature review, semi-structured telephone interviews were carried out with GPs. The results were recorded using keywords and evaluated in terms of content and topic. New topics were identified in the first series of interviews (n = 9). A second series (n = 5) revealed no new topics, so we assumed that all relevant topics had been included. Based on these results, a questionnaire was developed that aimed to take all aspects into consideration, while being short enough to ensure a high response rate. The questionnaire was checked for comprehensibility by five GPs.

Structure of the questionnaire

This analysis contains eight demographic items, 48 closed items (response scales: yes/no, yes/probably yes/probably no/no, very low/low/moderate/high/very high) and two items requiring GPs to provide exact numbers (e.g. “How many COVID-19 tests did you perform last week?”). The full questionnaire development is explained in the Supplement. The items not used in this paper will be analyzed in the longitudinal arm of the COVI-Prim study. Out of the 48 items used in this analysis eight factors were calculated. Reflecting the items contained within them, the factors were named as follows: (1) preparedness for a pandemic, (2) testing suspected cases, (3) protection of staff, (4) provision of information to GP, (5) perception of risk, (6) self-confidence, (7) decrease in number of patient contacts, (8) efforts to control the spread of the disease. Factor scores ranged from 0–10. The internal consistency (Cronbach’s Alpha) of these eight factors used in this analysis ranged from α = .48 to α = .85 (S1 Table in S1 File).

Survey

The questionnaire was transferred to LimeSurvey®. Invitations to GPs to respond to the questionnaire were sent out by participating universities in Austria (Graz, Salzburg, Innsbruck) and Germany (Frankfurt, Bochum, Hanover, Marburg, Gießen, Dresden, Freiburg, LMU Munich, Muenster, Aachen) using their respective mailing lists. Local GP associations, the Association of General Practitioners in Bavaria, Lower-Saxony and Baden-Wuerttemberg, Austria, and the Austrian Forum for Primary Care (OEFOP) also invited their members to participate. In accordance with data protection regulations, the study team did not have direct access to mailing lists. As the lists probably overlapped, it is not possible to know precisely how many GPs were contacted or to calculate a response rate. At the beginning of the survey, participants received information about its length, the investigators, and the purpose of the study. After ending the survey, all data on the online platform was stored in SPSS files. GPs received no incentive to participate.

Statistics

Baseline characteristics are presented as mean ±SD or median (min-max), as appropriate. Categorical variables are provided as absolute numbers and in percent. In the main analysis, environmental variables (country of survey: Germany vs. Austria; size of town of practice: < 5,000 vs. 5,000 - <20,000 vs. 20,000 - <100,000 vs. ≥100,000; type of practice: single-handed vs. not single handed) that may have influenced the responses were analyzed using General Linear Models. The main effects and all two-way interactions were therefore analyzed. Bonferroni correction was used to take account of multiple testing. Estimated means and 95% confidence intervals were used to present the results. For a better understanding of the results, responses to the items of the factors were also presented. In this presentation, the response categories “yes” and “probably yes” and the response categories “probably no” and “no” were combined. Items that did not belong to a factor were analyzed using ordinal regression analysis. No statistical correction was carried out to adjust for non-representative samples.

Ethics

The study protocol has been approved by the local ethics committee of Goethe University Frankfurt, Germany (20–619). According to the Austrian law, this study does not require an ethical approval.

Results

Demographics

The survey was answered by 2,187 Austrian and German GPs during the early phase of the COVID-19-pandemic (3rd April to 30th April). The majority of GPs were male (55.6%), practiced in a city with fewer than 20,000 inhabitants (59.4%) and had a single-handed practice (57.7%). Mean age of the GPs was 52.5 years (SD: 9.6). In the week prior to answering the questionnaire, 56.1% of the GPs (n = 1226) ordered at least one COVID-19 test. In total 13,520 tests were ordered. Of the 1,226 GPs that ordered COVID-19 tests, 41.0% (n = 503; 41 GPs did not answer the question on the test results) received positive results for 1,593 patients (12.1% of 13,139 tests; 12.1%). All demographic characteristics are provided in Table 1.

Table 1. Baseline demographics.

  All Germany Austria
  n = 2187 n = 1287 n = 900
Age (years) 52.2 ± 9.6 51.7 ± 9.5 53.8 ± 9.6
Sex      
    male 1217 (55.6%) 673 (52.3%) 544 (60.4%)
    female 965 (44.1%) 609 (47.3%) 356 (39.6%)
    other 5 (0.2%) 5 (0.4%) 0 (0.0%)
Size of town of practice      
    < 5,000 658 (30.1%) 264 (20.5%) 394 (43.8%)
    5,000 - <20,000 642 (29.4%) 421 (32.7%) 221 (24.6%)
    20,000 - <100,000 635 (16.1%) 287 (22.3%) 66 (7.3%)
    ≥100,000 534 (24.4%) 315 (24.5%) 219 (24.3%)
Type of practice      
    single-handed 1262 (57.7%) 505 (39.2%) 757 (84.1%)
    not single-handed 952 (42.3%) 782 (60.8%) 143 (15.9%)
Position in the practice      
    employed 213 (9.7%) 202 (15.7%) 11 (1.2%)
    owner 1945 (88.9%) 1080 (83.9%) 865 (96.1%)
    locum 29 (1.3%) 5 (0.4%) 24 (2.7%)
Year practice was established median: 2003 2005 2003
Range: 1975–2020 1975–2020 1975–2020
GPs that ordered COVID-19 tests in previous 7 days      
    no 760 (34.8%) 289 (22.5%) 471 (52.3%)
    yes 1226 (56.1%) 916 (71.2%) 310 (34.4%)
    missing 201 (9.2%) 82 (6.4%) 119 (13.2%)
GPs with patients with positive COVID-19 test results in previous 7 days      
(n = 1226)      
    no 682 (55.6%) 520 (56.8%) 162 (52.3%)
    yes 503 (41.0%) 368 (40.2%) 135 (43.5%)
    missing 41 (3.3%) 28 (3.1%) 13 (4.1%)

Of the 2,187 GPs, 1,989 (90.9%) rated enough items to be included in the analysis. The median time required to answer the questionnaire was 14.1 minutes (IQR: 10.5–20.2 minutes) in Austria and 13.4 minutes (IQR: 9.8–19.0) in Germany. The completion rate of the survey was 79.7% in Austria and 85.2% in Germany.

Overall results

GPs gave low ratings to their preparedness for a pandemic (mean: 2.7; 95% CI: 2.5–2.8, n = 1989), testing of suspected cases (3.3, 95%CI 3.2–3.4) and efforts to protect staff (2.0 95%CI 1.9–2.1). The provision of information to GPs (4.3, 95%CI: 4.2–4.4) and the perception of risk (5.1 95%CI 4.9–5.2) were rated as moderate. On the other hand, the participants rated their self-confidence (7.7, 95%CI 7.5–7.8), a decrease in patient contacts (6.8, 95%CI 6.7–7.0) and their efforts to control the spread of the disease (7.3, 95%CI 7.2–7.4) highly.

Pandemic preparedness

Looking back to the beginning of the pandemic, 88.2% of GPs said they did not have enough protective equipment and 91.4% stated that they did not receive sufficient information on how much protective equipment they needed. Furthermore, a substantial number of GPs did not know where to procure protective equipment (78.3%) and said their practice was not well prepared for the COVID-19 pandemic (77.2%).

Testing of suspected cases

Of the participants, 92.5% agreed that GPs should decide which patients should undergo testing for COVID-19. The idea of a telephone hotline for the exclusive use of medical staff ordering COVID-19 tests was approved by 86.9% of respondents. Of the GPs, 83.6% rejected the idea that all suspected cases of COVID-19 should be sent directly to hospital to enable them to focus on other patients. Furthermore, a large number of GPs said too little testing is performed (71.9%) and that they did not have adequate access to tests at the beginning of the pandemic (71.0%).

Decrease in patient contacts

Of the GPs, 95.2% had less contact to patients as a result of the pandemic. Of these, 71.9% said they had less workload at the time because many patients are avoiding coming to the practice.

Information

Of the GPs, 71.4% said they had received insufficient information from public bodies. Before officially informing GPs of new developments, public authorities distributed important information to the general public via the media (70.9%).

Self-confidence

Almost all the GPs said they knew what to do in suspected cases of COVID-19 (99.1%), and 82.1% were convinced they knew enough to provide optimal care for their patients during the pandemic.

Efforts to control the spread of the virus in the practice

Almost all GPs tried to gain enough information from patients by phone beforehand to know whether they were dealing with a suspected case of COVID-19 (98.5%), and they took precautions to ensure that suspected cases did not come into contact with other patients in their practice (97.4%). Over 80% of GPs avoided treating patients with mild symptoms that were not clearly linked to suspected cases of COVID-19 in their practice and preferred to attend to them by phone or online (87.9%). The distribution of responses is given in S1 Table.

Economic aspects

60.0% of GP were concerned about how the pandemic would affect their own and their employees’ economic prospects.

Regional differences

Differences in the GP’s responses were found to depend on the country in which the survey was conducted, the size of the city in which the practice was located and whether the practice was single-handed or not. No interactions between observed variables were significant.

Compared to Austrian GPs, German GPs rated their self-confidence lower (Germany: 7.5 95%CI: 7.4–7.6 vs. Austria: 7.8 95%CI: 7.6–8.0; p = .009), as they did their efforts to control the spread of SARS-CoV-2 (Germany: 7.1 95%CI: 7.0–7.2 vs. Austria: 7.5 95%CI: 7.3–7.6; p = .001). However, they rated their testing of suspected cases higher (Germany: 4.0 95%CI: 3.9–4.2 vs. Austria: 2.5 95%CI: 2.3–2.7; p = .009) and were more likely to say the number of patient contacts had decreased (Germany: 7.1 95%CI: 7.0–7.1 vs. Austria: 6.6 95%CI: 6.4–6.8; p < .001) (Table 2, Fig 1). Looking at single items, the biggest difference between German and Austrian GPs was found in testing, with 62.8% of German GPs saying too little testing was carried out, compared to 84.9% of Austrian GPs, and 42.4% of German GPs saying they had adequate access to tests at the beginning of the pandemic, compared to 9.7% of Austrian GPs. Regarding the items that did not belong to an factor the following differences between Austrian and German GPs were observed. Austrian GPs were less worried about how the pandemic will affect their economic situation (p < .001), kept a close eye on themselves and their employees to see whether anyone was showing initial symptoms of an infection (p = .002) and more often had to take on patients from colleagues that had closed their practice because of quarantine (p < .001) (S3 Table).

Table 2. Mean and 95%CI for each factor of the evaluation of the pandemic for the whole group and subgroups.

    Type of practice Country of survey City size
(single-handed)
  overall yes no Austria Germany <5,000 5,000 – 20,000 ≥ 100,000
<20,000
  <100,000
Preparedness for 2.7 2.5 2.8 2.6 2.7 2.7 2.5 2.8 2.6
a pandemic (2.5–2.8) (2.4–2.7) (2.6–3.0) (2.4–2.8) (2.6–2.9) (2.5–2.8) (2.4–2.7) (2.5–3.1) (2.4–2.8)
Testing of 3.3 3.2 3.3 2.5 4.0* 3.2 3.3 3.4 3.2
suspected cases (3.2–3.4) (3.1–3.3) (3.2–3.5) (2.3–2.7) (3.9–4.2) (3.1–3.4) (3.1–3.4) (3.1–3.6) (3.0–3.4)
Protection of staff 2 1.8 2.2 2.1 1.9 2 2.1 1.9 2
(1.9–2.1) (1.7–2.0) (2.0–2.4) (1.9–2.4) (1.7–2.0) (1.8–2.2) (1.9–2.3) (1.6–2.2) (1.8–2.2)
Provision of 4.3 4.3 4.3 4.2 4.5 4.4 4.3 4.4 4.2
information to GPs (4.2–4.4) (4.2–4.5) (4.1–4.5) (3.9–4.4) (4.3–4.6) (4.2–4.6) (4.1–4.5) (4.1–4.7) (3.9–4.4)
Perception of risk 5.1 5 5.1 4.8 5.3 5.1 5 5.1 5
(4.9–5.2) (4.8–5.2) (4.9–5.4) (4.6–5.1) (5.1–5.4) (4.9–5.4) (4.8–5.3) (4.7–5.5) (4.8–5.3)
Self-confidence 7.7 7.7 7.6 7.8 7.5* 7.6 7.6 8.0 7.4,§
(7.5–7.8) (7.5–7.7) (7.5–7.8) (7.6–8.0) (7.4–7.6) (7.5–7.8) (7.5–7.8) (7.7–8.2) (7.2–7.5)
Decrease in number 6.8 6.9 6.8 6.6 7.1* 6.7 6.7 7 6.9
of patient contacts (6.7–7.0) (6.8–7.1) (6.5–7.0) (6.4–6.8) (7.0–7.2) (6.5–6.9) (6.6–6.9) (6.7–7.3) (6.7–7.1)
Efforts to control 7.3 7.2 7.4 7.5 7.1* 7.3 7.3 7.2 7.3
the spread of the (7.2–7.4) (7.1–7.3) (7.3–7.6) (7.3–7.6) (7.0–7.2) (7.2–7.5) (7.2–7.5) (7.0–7.4) (7.2–7.5)
disease in the practice                  

Significant differences are in bold. (Scale values range from 0–10)

* Comparison Austria vs. Germany, p < .05

… Variable city size: Post Hoc comparison to ≥ 100,000, p < .05 (Bonferroni corrected)

… Variable city size: Post Hoc comparison to <5,000, p < .05 (Bonferroni corrected)

§ … Variable city size: Post Hoc comparison to 20,000 - <100,000, p < .05 (Bonferroni corrected)

Fig 1. Differences between German and Austrian GPs in their evaluation of the pandemic (Austria: n = 900; Germany: n = 1287).

Fig 1

While no differences in factor score were found between GPs working in single-handed practice or not did, responses to items, that did not belong to a factor were observe. GPs working in single-handed practice were more worried about how the pandemic will affect their economic situation (p = .018), kept a close eye on themselves and their employees to see whether anyone was showing initial symptoms of an infection (p < .001), had less sufficient information on the type of personal protective equipment (p = .017) and had not so often take on patients from colleagues that had closed their practice because of quarantine (p = .046) (S3 Table).

GPs in cities with 100,000 inhabitants or more rated their self-confidence lower than GPs in towns with fewer than 5,000 (p = .041) and towns with 20,000–100,000 (p < .001) inhabitants (Fig 2, Table 2). Analyzing the items used to calculate the self-confidence score, the largest difference can be observed in GPs’ conviction that their knowledge was sufficient to provide optimal care for their patients during the pandemic. While 87.1% of GPs in cities with 20,000–100,000 inhabitants were convinced, the number fell to 82.9% in cities with fewer than 5,000 inhabitants and to 79.0% in cities with 100,000 or more inhabitants. Regarding the items that did not belong to a factor the following differences were observed. GPs in cities with 100,000 or more inhabitants were more worried about how the pandemic will affect their economic situation (p = .001) and more often had to take on patients from colleagues that had closed their practice because of quarantine (p = .003) compared to GPs in towns with fewer than 5,000 (S3 Table).

Fig 2. Differences in the evaluation of the pandemic of GPs with practices in cities of different sizes.

Fig 2

Discussion

Our survey covered the specific problems and experiences of more than two thousand general practitioners in Austria and Germany at the beginning of the COVID-19 pandemic. The high level of participation demonstrates the interest and concern of this group. In the early stages, GP practices were not well prepared and did not have enough protective equipment. GPs did not receive sufficient information from public stakeholders but were very active on informal digital networks involving their professional peer group. Overall, they had fewer patient contacts. A majority wanted to decide themselves whom to test, and to have a higher number of tests made available to GPs themselves. They were concerned about the economic outlook but they were generally self-confident in terms of dealing with suspected and confirmed cases of COVID-19.

Considering its scale and abruptness, the reported lack of preparation for an event such as the COVID-19 pandemic is not surprising. Even though GPs immediately went to great lengths to procure enough protective equipment and to re-organize and adapt standard procedures in their practices, some–as in other countries–also had to work without sufficient PPE [1719]. Since the availability of PPE is essential to ensuring the continuous and safe provision of care during a pandemic, it is critical to incorporate primary care practices in the procurement of PPE. Existing structures should support the development of a joint national response plan to ensure that primary care is adequately involved [10].

Although many of the challenges such as that mentioned above were observed internationally, some regional differences stand out. In particular, GPs in Austria were not initially involved in testing procedures. Instead, the population in Austria was encouraged to contact an official health hotline in case of symptoms or suspicion of infection. Hence, GPs were overlooked in their role as gatekeepers in primary care. For GPs, this is likely to have been particularly frustrating, as the vast majority are convinced they know how to manage patients with a suspected infection and are willing to do so.

Furthermore, in the current situation it is especially important to motivate primary care practitioners, as they are in the frontline in terms of contact with the community [3]. The role of the GP is to decide which patients need hospital care and to monitor others at home [20]. This is the only way to ensure that important resources in hospitals are not overburdened. Experts’ concerns that a significant number of patients may die or suffer harm due to delayed access to usual medical care [21, 22] are also important and are reflected in our survey. As noted above, the number of patients visiting primary care practices decreased during the COVID-19 pandemic. People had strict stay-at-home orders or were afraid of infection. However, a few weeks after the lockdown, there was widespread criticism that this may have led to significant collateral damage. Several recently published articles pointed out that fewer patients were diagnosed with serious medical conditions such as stroke [23], acute coronary syndrome [24], atrial fibrillation [25] and cancer [26]. Furthermore, the WHO warned that measures designed to slow the spread of the coronavirus might also delay vaccination programs and thereby speed up the spread of other vaccine-preventable diseases [27].

General practitioners are responsible for the population as a whole, and the COVID-19 pandemic affected everyone. While children usually only experience mild or asymptomatic disease symptoms [28], they are also strongly affected by social isolation. A lack of structure and support from schools can increase anxiety and potentially impact mental health [29]. Other vulnerable groups to consider are elderly people that are living alone and for whom the use of online communication systems is often not feasible, as well as those with mental health problems, or people living in poor socio-economic conditions. They are all part of the patient collective in a primary care setting. We therefore need strategies to avoid future collateral damage that ensure access to primary care, even at times of high infection rates. Possible solutions, such as the greater use of telemedicine appointments and triage for certain patient groups according to the severity and urgency of a consultation, are surveyed in our longitudinal study (see supporting information), for which the analysis is ongoing.

But telemedicine alone is not enough. About 60% of GPs reported financial and economic concerns. This suggests that existing remuneration mechanisms for primary care need to be adapted or amended during a pandemic. Basu et al. estimated that the losses to primary care practices resulting from the pandemic amounted to about 15 billion USD in the U.S. alone [30].While SARS-CoV-2 is certainly the most serious pandemic since the influenza pandemic of 1917–18 [31], it has not been the only one in recent years. The H1N1 virus in 2009 was also declared responsible for an influenza pandemic and resulted in widespread preparations. However, it had far less impact on the population than expected, and a specific vaccine and treatment was available early [32]. SARS-CoV-1 in 2003 resulted in a similar public health response in strongly affected regions like Toronto [33]. Many of the issues that arose during that outbreak are mirrored in this pandemic on a global scale and can be found in the results of our study. Such pandemics, as well as seasonal influenza epidemics, lead to a surge in hospital bed demand and primary care consultations [34]. The COVID-19 pandemic is somewhat different because a strong focus was placed on saving health care resources in countries that had time to prepare before the need for them had arisen.

Our study has some limitations. Firstly, the questionnaire was developed in a very short time so that it could be delivered when the situation was most acute. Even though we tried to include all relevant topics, some issues may have been missed. Secondly, we could not calculate the response rate because a systematic area-wide survey was not possible in the time frame we permitted ourselves. However, the number of responses far exceeded our expectations, especially considering the difficulties that are usually encountered in recruiting GPs for research projects [35]. In addition, the questionnaire was completed by a very high percentage of participants. Thirdly, the recruitment process through regional networks and professional associations led to the heterogeneous selection of participants, which may have limited representativeness. One further limitation is that our survey was only carried out among GPs and did not involve other team members from the primary care setting.

Primary care is an important and vital resource for dealing with a pandemic like COVID-19. The workforce is confident and willing to take an active role, but needs to be given the opportunity and provided with the necessary conditions to do so. As GPs work on the frontline, they should be adequately supported, both in terms of the provision of protective equipment and financial security during the active phase of the pandemic. To ensure a quick and effective response to any new crisis, general practitioners in primary care should be involved in a national coordinated strategy that includes all relevant parties.

Supporting information

S1 Fig. Differences between GPs in single-handed and not single-handed practices in their evaluation of the pandemic.

(DOCX)

S1 Table. Response distribution (%) for all items.

(DOCX)

S2 Table. Difference in the responses of Austrian and German GPs.

Percentages were calculated as %German GPs minus %Austrian GPs. Responses which were more often chosen by German GPs are marked green and responses which were more often chosen by Austrian GPs are marked red.

(DOCX)

S3 Table. Differences in responses to items that do not belong to a factor (multivariable ordinal or binary logistic regression results; Bonferroni correction).

(DOCX)

S1 File. Project description.

Questionnaire development, Structure of the Questionnaires, Translation, Survey, Statistics, Ethics.

(DOCX)

S2 File. Checklist for Reporting Results of Internet E-Surveys (CHERRIES).

(DOCX)

S3 File. COVI Prim Baseline questionnaire—English.

(DOCX)

S4 File. COVI Prim Baseline questionnaire–German.

(DOCX)

Acknowledgments

We would like to thank all participating general practitioners, and the institutions that were willing to send the link to our questionnaire to their network partners.

Data Availability

The authors have uploaded an additional minimal data set to Data Archiving and Networked Services (DANS) which is available at https://doi.org/10.17026/dans-z8u-unbv.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Kunin M, Engelhard D, Piterman L, Shane T. Response of general practitioners to infectious disease public health crises: an integrative systematic review of the literature. Disaster Med Public Health Prep. 2013;7(5):522–33. doi: 10.1017/dmp.2013.82 [DOI] [PubMed] [Google Scholar]
  • 2.World Health O. Primary health care. 2020. [Google Scholar]
  • 3.Dunlop C, Howe A, Li D, Allen LN. The coronavirus outbreak: the central role of primary care in emergency preparedness and response. BJGP Open. 2020;4(1). doi: 10.3399/bjgpopen20X101041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wong WCW. How did general practitioners protect themselves, their family, and staff during the SARS epidemic in Hong Kong? J Epidemiol Community Health. 2004;58(3):180–5. doi: 10.1136/jech.2003.015594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lee JQ, Loke W, Ng QX. The Role of Family Physicians in a Pandemic: A Blueprint. Healthcare. 2020;8(3):198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lee KP, Wong C, Chan D, Kung K, Luk L, Wong MCS, et al. Family medicine vocational training and career satisfaction in Hong Kong. BMC Fam Pract. 2019;20(1):139. doi: 10.1186/s12875-019-1030-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wilson N, Baker M, Crampton P, Mansoor O. The potential impact of the next influenza pandemic on a national primary care medical workforce. Hum Resour Health. 2005;3(1):7. doi: 10.1186/1478-4491-3-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Anikeeva O, Braunack‐Mayer AJ, Street JM. How will Australian general practitioners respond to an influenza pandemic? A qualitative study of ethical values. Med J Aust. 2008;189(3):148–50. doi: 10.5694/j.1326-5377.2008.tb01948.x [DOI] [PubMed] [Google Scholar]
  • 9.Drucksache17/12051. Deutscher Bundestag; 2013.
  • 10.Patel MS, Phillips CB, Pearce C, Kljakovic M, Dugdale P, Glasgow N. General Practice and Pandemic Influenza: A Framework for Planning and Comparison of Plans in Five Countries. PLOS ONE. 2008;3(5):e2269. doi: 10.1371/journal.pone.0002269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Liu Y. China’s public health-care system: facing the challenges. Bull World Health Organ. 2004;82:532–8. [PMC free article] [PubMed] [Google Scholar]
  • 12.Stang A, Stang M, Jöckel K-H. Estimated Use of Intensive Care Beds Due to COVID-19 in Germany Over Time. Dtsch Arztebl Int. 2020;117(19):329–35. doi: 10.3238/arztebl.2020.0329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Amtliches Dashboard COVID19.
  • 14.de Lusignan S, Correa A, Smith GE, Yonova I, Pebody R, Ferreira F, et al. RCGP Research and Surveillance Centre: 50 years’ surveillance of influenza, infections, and respiratory conditions. Br J Gen Pract. 2017;67(663):440–1. doi: 10.3399/bjgp17X692645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Eysenbach G. Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi: 10.2196/jmir.6.3.e34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.COVI-Prim study description. DRKS—German clinical trials register; 2020.
  • 17.Ahmed J, Malik F, Bin Arif T, Majid Z, Chaudhary MA, Ahmad J, et al. Availability of Personal Protective Equipment (PPE) Among US and Pakistani Doctors in COVID-19 Pandemic. Cureus. 2020;12(6). doi: 10.7759/cureus.8550 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Dyer C. Covid-19: Doctors make bid for public inquiry into lack of PPE for frontline workers. BMJ. 2020;369. doi: 10.1136/bmj.m1905 [DOI] [PubMed] [Google Scholar]
  • 19.Iacobucci G. Covid-19: Doctors still at “considerable risk” from lack of PPE, BMA warns. BMJ. 2020:m1316. [DOI] [PubMed] [Google Scholar]
  • 20.Krist AH, DeVoe JE, Cheng A, Ehrlich T, Jones SM. Redesigning Primary Care to Address the COVID-19 Pandemic in the Midst of the Pandemic. Ann Fam Med. 2020;18(4):349–54. doi: 10.1370/afm.2557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Masroor S. Collateral damage of COVID-19 pandemic: Delayed medical care. J Card Surg. 2020;35(6):1345–7. doi: 10.1111/jocs.14638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Schaffert M, Zimmermann F, Bauer L, Kastner S, Schwarz A, Strenger V, et al. Austrian study shows that delays in accessing acute paediatric healthcare outweighed the risks of COVID-19. Acta Paediatr. 2020;n/a(n/a). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Montaner J, Barragán-Prieto A, Pérez-Sánchez S, Escudero-Martínez I, Moniche F. Sánchez-Miura JA, et al. Break in the Stroke Chain of Survival due to COVID-19. Stroke. 2020;51(8):2307–14. doi: 10.1161/STROKEAHA.120.030106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020;41(19):1852–3. doi: 10.1093/eurheartj/ehaa314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Holt A, Gislason GH, Schou M, Zareini B, Biering-Sørensen, Phelps M, et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020:ehaa494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750–1. doi: 10.1016/S1470-2045(20)30265-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hoffman J, Maclean R. Slowing the Coronavirus Is Speeding the Spread of Other Diseases. The New York Times; 14th June 2020. [Google Scholar]
  • 28.Choi S-H, Kim HW, Kang J-M, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease 2019 in children. Clin Exp Pediatr. 2020;63(4):125–32. doi: 10.3345/cep.2020.00535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Crawley E, Loades M, Feder G, Logan S, Redwood S, Macleod J. Wider collateral damage to children in the UK because of the social distancing measures designed to reduce the impact of COVID-19 in adults. BMJ Paediatr Open. 2020;4(1):e000701. doi: 10.1136/bmjpo-2020-000701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Basu S, Phillips RS, Phillips R, Peterson LE, Landon BE. Primary Care Practice Finances In The United States Amid The COVID-19 Pandemic. Health Aff. 2020: doi: 10.1377/hlthaff.2020.00794 [DOI] [PubMed] [Google Scholar]
  • 31.He D, Zhao S, Li Y, Cao P, Gao D Lou Y, et al. Comparing COVID-19 and the 1918–19 influenza pandemics in the United Kingdom. Int J Infect Dis. 2020;98:67–70. doi: 10.1016/j.ijid.2020.06.075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Donaldson LJ, Rutter PD, Ellis BM, Greaves FEC, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. The BMJ. 2009;339. doi: 10.1136/bmj.b5213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lim S, Closson T, Howard G, Gardam M. Collateral damage: the unforeseen effects of emergency outbreak policies. Lancet Infect Dis. 2004;4(11):697–703. doi: 10.1016/S1473-3099(04)01176-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Simonsen KA, Hunskaar S, Sandvik H, Rortveit G. Capacity and Adaptations of General Practice during an Influenza Pandemic. PLOS ONE. 2013;8(7):e69408. doi: 10.1371/journal.pone.0069408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Parkinson A, Jorm L, Douglas KA, Gee A, Sargent GM, Lujic S, et al. Recruiting general practitioners for surveys: reflections on the difficulties and some lessons learned. Aust J Prim Health. 2014. [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Kamal Gholipour

5 Feb 2021

PONE-D-20-36154

COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19

PLOS ONE

Dear Dr. Avian,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

This is a good study focused on “Challenges for Austrian and German general practitioners during

initial phase of COVID-19”. Please address the following points before external review:

• You must provide a rational for absence of Ethics approval for Austria as mentioned in appendix table 1 considered as Not Applicable.

• The result of open-end question (free text in questionnaire) was not presented in manuscript. It appears the most related part of questionnaire to your manuscript title was this section, “biggest challenge, supporting factor”.

• The results of last table in questionnaire were not presented at all. And were not analyzed in relation to other factors.

• Considering the unity of covi-prim project please clarify your rational to publish the result of this project Separately.

Please submit your revised manuscript by Mar 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Kamal Gholipour, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"The study was financed by the cooperating University Institutes without any external financial

130 support"

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The authors received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 10;16(6):e0251736. doi: 10.1371/journal.pone.0251736.r002

Author response to Decision Letter 0


22 Feb 2021

• You must provide a rational for absence of Ethics approval for Austria as mentioned in appendix table 1 considered as Not Applicable.

Response: When we were asking the head of the local ethic committee at the Medical University Graz for an ethical approval, we were told that according to the Austrian law, this study does not require an ethical approval. This information will be added in the method section in the paragraph Ethics at page 6 and the approval from Germany will be uploaded as a supplement file.

• The result of open-end question (free text in questionnaire) was not presented in manuscript. It appears the most related part of questionnaire to your manuscript title was this section, “biggest challenge, supporting factor”.

Response: Prior to the writing of our manuscript we were discussing this aspect in detail and decided that we do not include the comments. This decision was based on the high number (more than 3.500 comments) and the heterogeneity of the comments. We observed that comments differed over time and were strongly dependent of the region of the responding doctors. In our opinion, it is not possible to report these results in one paragraph. We are currently preparing a second manuscript reporting on the interesting results to present the comments in detail. This information can be added in our actual manuscript for PLOS ONE.

• The results of last table in questionnaire were not presented at all. And were not analyzed in relation to other factors.

Response: We have not analyzed this items in the first version of the manuscript, because, these items do not belong to one of the dimensions of the questionnaire. However, based on your suggestion, we now added the most important results in the manuscript and the other results in the appendix (table S5)

• Considering the unity of covi-prim project please clarify your rational to publish the result of this project separately.

Response: Considering the number of different aspects of the COVI-Prim project, we think that it is not possible to present all results within one manuscript. There are so many aspects (changes over time, differences between countries, differences in baseline between GPs answering the first time at the beginning of the pandemic and GPs answering at the beginning of the summer, a.s.o.) that each of these aspect could be described in several further manuscripts. Therefore, we decided to write one “starter” manuscript including all protocol relevant information in the main text and the supplement that we would be able to reference it within every subsequent publication.

Attachment

Submitted filename: Revision_PLOS one_ask_aa.docx

Decision Letter 1

Kamal Gholipour

3 May 2021

COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19

PONE-D-20-36154R1

Dear Dr. Avian,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kamal Gholipour, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The introduction and title are well written and the aim of the study is clear with an obvious gap of knowledge.

The methods is well written and reproducible

In the results I recommend investigating the association between level of knowledge and experience or grades in medical school. Otherwise the results are well represented

The discussion is well written however I recommend comparing the results with other studies published on this topic which are numerous and regional.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Kirellos Said Abbas

Acceptance letter

Kamal Gholipour

17 May 2021

PONE-D-20-36154R1

COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19

Dear Dr. Avian:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kamal Gholipour

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Differences between GPs in single-handed and not single-handed practices in their evaluation of the pandemic.

    (DOCX)

    S1 Table. Response distribution (%) for all items.

    (DOCX)

    S2 Table. Difference in the responses of Austrian and German GPs.

    Percentages were calculated as %German GPs minus %Austrian GPs. Responses which were more often chosen by German GPs are marked green and responses which were more often chosen by Austrian GPs are marked red.

    (DOCX)

    S3 Table. Differences in responses to items that do not belong to a factor (multivariable ordinal or binary logistic regression results; Bonferroni correction).

    (DOCX)

    S1 File. Project description.

    Questionnaire development, Structure of the Questionnaires, Translation, Survey, Statistics, Ethics.

    (DOCX)

    S2 File. Checklist for Reporting Results of Internet E-Surveys (CHERRIES).

    (DOCX)

    S3 File. COVI Prim Baseline questionnaire—English.

    (DOCX)

    S4 File. COVI Prim Baseline questionnaire–German.

    (DOCX)

    Attachment

    Submitted filename: Revision_PLOS one_ask_aa.docx

    Data Availability Statement

    The authors have uploaded an additional minimal data set to Data Archiving and Networked Services (DANS) which is available at https://doi.org/10.17026/dans-z8u-unbv.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES